1. Home
  2. ABP vs CMBM Comparison

ABP vs CMBM Comparison

Compare ABP & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • CMBM
  • Stock Information
  • Founded
  • ABP 2004
  • CMBM 2011
  • Country
  • ABP United States
  • CMBM United States
  • Employees
  • ABP N/A
  • CMBM N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ABP Health Care
  • CMBM Technology
  • Exchange
  • ABP Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • ABP 12.3M
  • CMBM 14.3M
  • IPO Year
  • ABP N/A
  • CMBM 2019
  • Fundamental
  • Price
  • ABP $0.32
  • CMBM $0.94
  • Analyst Decision
  • ABP Strong Buy
  • CMBM Strong Buy
  • Analyst Count
  • ABP 1
  • CMBM 2
  • Target Price
  • ABP $4.00
  • CMBM $5.50
  • AVG Volume (30 Days)
  • ABP 15.4M
  • CMBM 1.6M
  • Earning Date
  • ABP 08-18-2025
  • CMBM 08-07-2025
  • Dividend Yield
  • ABP N/A
  • CMBM N/A
  • EPS Growth
  • ABP N/A
  • CMBM N/A
  • EPS
  • ABP N/A
  • CMBM N/A
  • Revenue
  • ABP $183,000.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • ABP N/A
  • CMBM N/A
  • Revenue Next Year
  • ABP N/A
  • CMBM $17.73
  • P/E Ratio
  • ABP N/A
  • CMBM N/A
  • Revenue Growth
  • ABP 88.66
  • CMBM N/A
  • 52 Week Low
  • ABP $0.15
  • CMBM $0.23
  • 52 Week High
  • ABP $11.19
  • CMBM $2.18
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • CMBM 61.88
  • Support Level
  • ABP N/A
  • CMBM $0.65
  • Resistance Level
  • ABP N/A
  • CMBM $1.49
  • Average True Range (ATR)
  • ABP 0.00
  • CMBM 0.18
  • MACD
  • ABP 0.00
  • CMBM 0.05
  • Stochastic Oscillator
  • ABP 0.00
  • CMBM 49.77

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: